Supernus Pharmaceuticals Inc (SUPN)

NASDAQ · Pharmaceuticals

48.78
+0.51 (+1.05%)
Updated Aug 18, 6:00 PM ET
AI Rating
Buy
Overall Score
67
Trend
64
Momentum
76
Risk
58

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

Supernus Pharmaceuticals Inc is trading at $48.78, up 1.05% on the session. The 50 day average sits at $46.41 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 55.4, which reads as strong, and MACD is bullish crossover. Volume is below average.

The nearest support is around $46.09 with resistance near $48.45, so that band frames the current range. Average daily movement is roughly $2.07, or about 4.2% of the share price, which is what any stop placement has to allow for. The overall health score of 67 out of 100 combines a trend score of 64, momentum of 76 and a risk score of 58.

Technical indicators

RSI (14)
55.4
strong
MACD
0.161
bullish crossover
SMA 20
46.75
SMA 50
46.41
SMA 200
--
unknown
ATR (14)
2.07
avg daily range
Support
46.09
Resistance
48.45
Volume vs 20d
0.33x
below average
Volatility
46.4%
annualised
1 month
+0.12%
3 months
-5.72%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.